Literature DB >> 21532726

A review on laboratory liver function tests.

Shivaraj Gowda1, Prakash B Desai, Vinayak V Hull, Avinash A K Math, Sonal N Vernekar, Shruthi S Kulkarni.   

Abstract

Laboratory liver tests are broadly defined as tests useful in the evaluation and treatment of patients with hepatic dysfunction. The liver carries out metabolism of carbohydrate, protein and fats. Some of the enzymes and the end products of the metabolic pathway which are very sensitive for the abnormality occurred may be considered as biochemical marker of liver dysfunction. Some of the biochemical markers such as serum bilirubin, alanine amino transferase, aspartate amino transferase, ratio of aminotransferases, alkaline phosphatase, gamma glutamyl transferase, 5' nucleotidase, ceruloplasmin, α-fetoprotein are considered in this article. An isolated or conjugated alteration of biochemical markers of liver damage in patients can challenge the clinicians during the diagnosis of disease related to liver directly or with some other organs. The term "liver chemistry tests" is a frequently used but poorly defined phrase that encompasses the numerous serum chemistries that can be assayed to assess hepatic function and/or injury.

Entities:  

Keywords:  5′ nucleotidase ; Laboratory liver test ; alanine amino transferase ; alkaline phosphatase ; aspartate amino transferase ; bilirubin ; ceruloplasmin ; gamma glutamyl transferase ; ratio of aminotransferases ; α-fetoprotein

Year:  2009        PMID: 21532726      PMCID: PMC2984286     

Source DB:  PubMed          Journal:  Pan Afr Med J


  45 in total

1.  Increased levels of gammaGT suggest the presence of bile duct lesions in patients with chronic hepatitis C: absence of influence of HCV genotype, HCV-RNA serum levels, and HGV infection on this histological damage.

Authors:  E Giannini; F Botta; A Fasoli; P Romagnoli; L Mastracci; P Ceppa; I Comino; A Pasini; D Risso; R Testa
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

2.  New concepts in bilirubin and jaundice: report of the Third International Bilirubin Workshop, April 6-8, 1995, Trieste, Italy.

Authors:  C Tiribelli; J D Ostrow
Journal:  Hepatology       Date:  1996-11       Impact factor: 17.425

3.  Elevated serum gamma-glutamyl-transferase (transpeptidase) and histological liver damage in alcoholism.

Authors:  A Wu; G Slavin; A J Levi
Journal:  Am J Gastroenterol       Date:  1976-04       Impact factor: 10.864

4.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

5.  The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.

Authors:  Edoardo Giannini; Federica Botta; Emanuela Testa; Paola Romagnoli; Simone Polegato; Federica Malfatti; Alessandra Fumagalli; Bruno Chiarbonello; Domenico Risso; Roberto Testa
Journal:  Am J Gastroenterol       Date:  2002-11       Impact factor: 10.864

6.  5'-Nucleotidase activities in sera and liver tissues of viral hepatitis patients.

Authors:  M Fukano; S Amano; F Hazama; S Hosoda
Journal:  Gastroenterol Jpn       Date:  1990-04

7.  Diagnostic criteria for acute liver failure due to Wilson disease.

Authors:  Christoph Eisenbach; Olivia Sieg; Wolfgang Stremmel; Jens Encke; Uta Merle
Journal:  World J Gastroenterol       Date:  2007-03-21       Impact factor: 5.742

8.  Diagnosis of Gilbert's syndrome. Reliability of the caloric restriction and phenobarbital stimulation tests.

Authors:  H F Thomsen; F Hardt; E Juhl
Journal:  Scand J Gastroenterol       Date:  1981       Impact factor: 2.423

9.  Serum adenosine deaminase, 5' nucleotidase and malondialdehyde in acute infective hepatitis.

Authors:  K Pratibha; Usha Anand; Rajni Agarwal
Journal:  Indian J Clin Biochem       Date:  2004-07

10.  Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004.

Authors:  Todd S Perlstein; Reena L Pande; Mark A Creager; Jennifer Weuve; Joshua A Beckman
Journal:  Am J Med       Date:  2008-09       Impact factor: 4.965

View more
  78 in total

1.  Influence of intranasal exposure of MPTP in multiple doses on liver functions and transition from non-motor to motor symptoms in a rat PD model.

Authors:  Indrani Datta; S R Mekha; Alka Kaushal; Kavina Ganapathy; Rema Razdan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-29       Impact factor: 3.000

2.  In Vivo Assessment of Immunogenicity and Toxicity of the Bacteriocin TSU4 in BALB/c Mice.

Authors:  Tapasa Kumar Sahoo; Prasant Kumar Jena; Bhumika Prajapati; Laxita Gehlot; Amiya Kumar Patel; Sriram Seshadri
Journal:  Probiotics Antimicrob Proteins       Date:  2017-09       Impact factor: 4.609

3.  After successful hepatitis C virus antiviral therapy: It looks that normal alanine aminotransferase level is not the normal.

Authors:  Mohamed El Kassas; Mohamed Alboraie; Aya Mostafa; Reem Ezzat; Adel El Tahan; Shimaa Afify; Ahmed Sweedy; Ibrahim Kabbash; Gamal Esmat
Journal:  J Clin Lab Anal       Date:  2017-07-28       Impact factor: 2.352

4.  Safety Assessment of Potential Probiotic Lactobacillus fermentum MTCC-5898 in Murine Model after Repetitive Dose for 28 Days (Sub-Acute Exposure).

Authors:  Mrinal Samtiya; Mohd Iqbal Bhat; Taruna Gupta; Suman Kapila; Rajeev Kapila
Journal:  Probiotics Antimicrob Proteins       Date:  2020-03       Impact factor: 4.609

5.  Gastroprotective activity and pharmacological safety evaluation of Eupatorium aschenbornianum.

Authors:  José Miguel Flores-Fernández; Eduardo Padilla-Camberos; Ofelia Fernández-Flores; Nestor Emmanuel Diaz-Martínez; Carla Patricia Barragán-Álvarez; Patricia Berenice Ramírez-Rodríguez
Journal:  Exp Ther Med       Date:  2019-10-10       Impact factor: 2.447

6.  Biodistribution and toxicity of epitope-functionalized dextran iron oxide nanoparticles in a pregnant murine model.

Authors:  Amir Bolandparvaz; Natalia Vapniarsky; Rian Harriman; Kenneth Alvarez; Jasmeen Saini; Zexi Zang; Judy Van De Water; Jamal S Lewis
Journal:  J Biomed Mater Res A       Date:  2020-02-26       Impact factor: 4.396

7.  Acute hepatologic and nephrologic effects of calcitriol in Syrian golden hamster (Mesocricetus auratus).

Authors:  Ewa Podgorska; Martyna Sniegocka; Marianna Mycinska; Wojciech Trybus; Ewa Trybus; Anna Kopacz-Bednarska; Olga Wiechec; Martyna Krzykawska-Serda; Martyna Elas; Teodora Krol; Krystyna Urbanska; Andrzej Slominski
Journal:  Acta Biochim Pol       Date:  2018-07-17       Impact factor: 2.149

8.  The Role of Ischemia Modified Albumin as a Biomarker in Patients with Chronic Liver Disease.

Authors:  Prashanth Ashok Kumar; Kavitha Subramanian
Journal:  J Clin Diagn Res       Date:  2016-03-01

9.  Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease.

Authors:  Aditya Ambade; Abhishek Satishchandran; Benedek Gyongyosi; Patrick Lowe; Gyongyi Szabo
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

Review 10.  Efficacy of elafibranor in patients with liver abnormalities especially non-alcoholic steatohepatitis: a systematic review and meta-analysis.

Authors:  Adnan Malik; Mahum Nadeem; Muhammad Imran Malik
Journal:  Clin J Gastroenterol       Date:  2021-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.